• search

Panacea Biotec gets WHO nod to supply Hepatitis-B vaccines

Written by: Staff
|

Mumbai, Aug 2 (UNI) Panacea Biotec has received pre-qualification certification from the World Health Organisation for supply of Hepatitis-B vaccine to United Nation agencies.

The overall estimated market for Hepatitis-B vaccine and its combinations is around 158 million doses which is estimated to go up to 185 million doses in 2008 and 888 million doses in 2009, a Company press release here today said.

In 2000, there were 5.7 million cases of acute Hepatitis-B infection and over 521,000 deaths worldwide, the release said adding that Hepatitis-B vaccine has been added in their immunization programme by 116 countries.

In India, Hepatitis-B vaccine is in the process of being listed in the list of ''essential vaccines''.

Panacea Biotec is marketing its Hepatitis-B vaccine and combination vaccines through its joint venture company, Chiron Panacea Vaccines.

''There has been constant growth in Panacea Biotec revenue due to strong vaccine sales and our inclusion in the list of pre-qualified suppliers of WHO will significantly enhance our presence in this segment,'' Company joint managing director Rajesh Jain said in the release.

UNI ARM MAZ AW2046

For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X

Loksabha Results

PartyLWT
BJP+0354354
CONG+09090
OTH19798

Arunachal Pradesh

PartyLWT
BJP33336
JDU077
OTH21012

Sikkim

PartyWT
SKM1717
SDF1515
OTH00

Odisha

PartyLWT
BJD12100112
BJP12223
OTH01111

Andhra Pradesh

PartyLWT
YSRCP0151151
TDP02323
OTH011

-
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more